Alixorexton’s Phase II performance sets it up for late-stage success, according to analysts at Truist Securities. Alkermes ...

Every year, CBSE toppers become symbols of discipline, strategy, and teenage resilience. But behind the glittering ...

A revised Mineral Resource Estimate (MRE) will underpin the updated Preliminary Economic Assessment (PEA) for the Ashram Project, which is expected to be delivered in H1 2026.

Upwork study reveals AI agents struggle to complete real-world tasks alone but excel by 70% when paired with human experts, ...

Our kids were never scared to work, even though they might not have always liked it,” Vern DeVries, Darian's father, said. It ...

Q2 2026 Management View President and CEO Shawn Singh announced "another major milestone in our PALISADE program. The last patient completed the randomized double-blind portion of our PALISADE-3 Phase ...

"What they found was that of all new drugs approved in the last 20 years, 12% came from the SBIR/STTR program," said Jere Glover.

Operator: Good morning, and welcome to BiomX Third Quarter 2025 Financial Results and Program Update Conference Call.

Company achieved FDA alignment on Phase 3 Oz-V trial for the treatment of 2L+ OPSCC, which will evaluate dual primary ...

R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advan ...

Business titan and Metro Pacific Investments Corp. chairman Manuel V. Pangilinan said his group is in the early stages of ...

Achieved additional $75 million in partnering proceeds from Sanofi and GileadGranted license to additional preclinical program to Gilead that leverages MacroGenics' novel T-cell engager platformRealig ...